CLINICAL SCIENCE
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
Roberto HeggI,
, André MattarI, João Nunes de Matos NetoII, José Luiz PedriniIII, Sabina Bandeira AleixoIV, Roberto Odebrecht RochaV, Renato Peixoto Cramer JuniorVI, Sylvie van-Eyll-RochaVII
Corresponding author
I Hospital Pérola Byington, Centro de Referência da Saúde da Mulher, São Paulo/SP, Brazil
II Hospital Universitário de Brasília, Brasília/DF, Brazil
III Hospital Nossa Senhora da Conceição, Porto Alegre/RS, Brazil
IV Hospital Evangélico de Cachoeiro de Itapemirim, Cachoeiro de Itapemirim/ES, Brazil
V Hospital Santa Marcelina, São Paulo/SP, Brazil
VI Hospital Bruno Born, Lajeado/RS, Brazil
VII Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo/SP, Brazil
Read
1519
Timeswas read the article
596
Total PDF
923
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 55 | 41 | 96 |
| 2025 11 | 222 | 190 | 412 |
| 2025 10 | 78 | 38 | 116 |
| 2025 9 | 62 | 25 | 87 |
| 2025 8 | 63 | 16 | 79 |
| 2025 7 | 81 | 20 | 101 |
| 2025 6 | 25 | 3 | 28 |
| 2025 5 | 25 | 7 | 32 |
| 2025 4 | 22 | 2 | 24 |
| 2025 3 | 16 | 7 | 23 |
| 2025 2 | 13 | 4 | 17 |
| 2025 1 | 14 | 7 | 21 |
| 2024 12 | 13 | 1 | 14 |
| 2024 11 | 20 | 11 | 31 |
| 2024 10 | 17 | 20 | 37 |
| 2024 9 | 24 | 10 | 34 |
| 2024 8 | 20 | 13 | 33 |
| 2024 7 | 22 | 24 | 46 |
| 2024 6 | 13 | 7 | 20 |
| 2024 5 | 13 | 9 | 22 |
| 2024 4 | 14 | 8 | 22 |
| 2024 3 | 12 | 10 | 22 |
| 2024 2 | 10 | 8 | 18 |
| 2024 1 | 9 | 11 | 20 |
| 2023 12 | 6 | 20 | 26 |
| 2023 11 | 11 | 17 | 28 |
| 2023 10 | 8 | 20 | 28 |
| 2023 9 | 7 | 13 | 20 |
| 2023 8 | 1 | 7 | 8 |
| 2023 7 | 4 | 9 | 13 |
| 2023 6 | 5 | 3 | 8 |
| 2023 5 | 2 | 0 | 2 |
| 2023 4 | 5 | 4 | 9 |
| 2023 3 | 4 | 1 | 5 |
| 2023 2 | 2 | 0 | 2 |
| 2023 1 | 0 | 6 | 6 |
| 2022 12 | 4 | 4 | 8 |
| 2022 11 | 1 | 0 | 1 |
Show all